Author

D. Yee

Institution: University of Minnesota

Observed institution: University of Minnesota

OpenAlex ID: A5144164662

Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial

2026 · J. Tseng, K. Dimitroff, et al. · Annals of Surgical Oncology · 1

Correction: ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial

2026 · J. Tseng, K. Dimitroff, et al. · Annals of Surgical Oncology

Correction: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial

2026 · J. Tseng, K. Dimitroff, et al. · Annals of Surgical Oncology

ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial

2026 · J. Tseng, K. Dimitroff, et al. · Annals of Surgical Oncology

Abstract PS3-11-10: Neoadjuvant HSP90 inhibition with ganetespib significantly improves distant relapse-free survival in I-SPY2 patients with HER2-negative breast cancer with low expression of immune genes and no DNA repair deficiency

2026 · T. B. V. Bui, D. M. Wolf, et al. · Clinical Cancer Research

Abstract PS1-01-09: Real-time monitoring for drug-induced interstitial lung disease with Trastuzumab Deruxtecan and Rilvegostomig combination therapy prevents persistent, symptomatic disease: Safety insights from the I-SPY2.2 platform trial

2026 · T. Kulkarni, R. Nanda, et al. · Clinical Cancer Research

Abstract PD6-07: Ctdna dynamics is most predictive of response in treatment-sensitive response-predictive subtypes of breast cancer: results from the I-SPY2 trial

2026 · M. Magbanua, D. Wolf, et al. · Clinical Cancer Research

Works count: 7

Citation count: 1

H-index: 1

I10-index: